Optimising zoledronate treatment holiday duration without loss of fracture prevention
- PMID: 38452785
- DOI: 10.1016/S2213-8587(24)00064-0
Optimising zoledronate treatment holiday duration without loss of fracture prevention
Conflict of interest statement
We declare no competing interests.
Comment on
-
Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years.Lancet Diabetes Endocrinol. 2024 Apr;12(4):247-256. doi: 10.1016/S2213-8587(24)00003-2. Epub 2024 Mar 4. Lancet Diabetes Endocrinol. 2024. PMID: 38452783 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
